Suanfarma Suanfarma

X

Find Apaziquone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Apaziquone
Also known as: 114560-48-4, Eoquin, Qapzola, Eo-9, Nor-701, Nsc-382459
Molecular Formula
C15H16N2O4
Molecular Weight
288.30  g/mol
InChI Key
MXPOCMVWFLDDLZ-NSCUHMNNSA-N
FDA UNII
H464ZO600O

Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities. Apaziquone is converted to active metabolites in hypoxic cells by intracellular reductases, which are present in greater amounts in hypoxic tumor cells. The active metabolites alkylate DNA, resulting in apoptotic cell death. This agent displays selectivity activity towards both hypoxic solid tumors, which exhibits higher expression of cytochrome P450 reductase, and well-oxygenated malignant cells that overexpress the bioreductive enzyme NQO1 (NAD(P)H: quinone oxidoreductase). Apaziquone may selectively sensitize hypoxic tumor cells to radiocytotoxicity.
1 2D Structure

Apaziquone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione
2.1.2 InChI
InChI=1S/C15H16N2O4/c1-16-10(3-2-6-18)9(8-19)13-14(16)12(20)7-11(15(13)21)17-4-5-17/h2-3,7,18-19H,4-6,8H2,1H3/b3-2+
2.1.3 InChI Key
MXPOCMVWFLDDLZ-NSCUHMNNSA-N
2.1.4 Canonical SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO
2.1.5 Isomeric SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)/C=C/CO
2.2 Other Identifiers
2.2.1 UNII
H464ZO600O
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1h-indole-4,7-dione)prop-beta-en-alpha-ol

2. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione

3. E 09

4. E-09

5. Eo 9

6. Eo-9

7. Eo9

8. Nsc 382,459

9. Nsc 382459

10. Nsc-382459

11. Qapzola

2.3.2 Depositor-Supplied Synonyms

1. 114560-48-4

2. Eoquin

3. Qapzola

4. Eo-9

5. Nor-701

6. Nsc-382459

7. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(e)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione

8. E-85/053

9. Eo9

10. 141304-51-0

11. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione

12. Apaziquonum

13. H464zo600o

14. Nsc-382456

15. Neoquin

16. Eo 9 (pharmaceutical)

17. Apaziquone [usan:inn]

18. Apaziquonum [inn-latin]

19. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-((1e)-3-hydroxy-1-propenyl)-1-methyl-

20. E09

21. E 09

22. 5-aziridin-1-yl-3-hydroxymethyl-2-((e)-3-hydroxy-propenyl)-1-methyl-1h-indole-4,7-dione

23. Nsc 382459

24. Eoquin (tn)

25. E-09

26. Apaziquone (usan/inn)

27. Nsc 382456

28. Unii-h464zo600o

29. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-

30. Apaziquone [usan]

31. (e)-5-(1-azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione

32. Apaziquone [mi]

33. Apaziquone [inn]

34. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-, (e)-

35. Chembl73822

36. Schembl367964

37. Schembl367965

38. E-85/050

39. Antineoplastic-382459

40. Dtxsid90869587

41. Chebi:177558

42. Zinc1536777

43. N1,n6-diethyl-3-methylhexanediamide

44. Nsc382459

45. Bcp9000309

46. Db12593

47. Cs-0006128

48. D02965

49. Q4779259

50. 1h-indole-4, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-

51. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methylindole-4,7-dione

52. (e)-5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione

53. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione

54. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione;

2.4 Create Date
2005-09-08
3 Chemical and Physical Properties
Molecular Weight 288.30 g/mol
Molecular Formula C15H16N2O4
XLogP3-0.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass288.11100700 g/mol
Monoisotopic Mass288.11100700 g/mol
Topological Polar Surface Area82.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity524
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY